Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study

References

• Krumholtz JS, Andriole GL. The surgery of prostate cancer: An update of contemporary radical prostatectomy and brachytherapy series. Sem Surgical Oncology 1999; 17(3)213–218
   PubMedGoogle Scholar
• Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gy external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998; 83(5)989–1001
   PubMed Web of Science ®Google Scholar
• Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. J American Med Association 1999; 281(17)1598–1604
   PubMed Web of Science ®Google Scholar
• Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and Goserelin. N Eng J Med 1997; 337(5)295–300
   PubMed Web of Science ®Google Scholar
• Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WU, Grignon D. Phase III trial of androgen suppression using Goserelin in unfavorable prognostic carcinoma of the prostate treated with definitive radiotherapy: Report of RTOG 85-31. J Clin Oncol 1997; 15: 1013–1021
   PubMed Web of Science ®Google Scholar
• Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV. Updated results of the phase III RTOG trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001; 49: 937–946
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Winter K, Hanks GE, Lawton CA, Russell AH, Machtay M. Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced non metastatic prostate cancer treated with radiation therapy. Int. J Radiat Oncol Biol Phys 2001; 49: 947–956
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer. Results from five randomized controlled trials. International Collaborative Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12(1)3–20
   PubMed Web of Science ®Google Scholar
• Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomized, multicentre trial. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation, & external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37(5)1059–1065
   PubMed Web of Science ®Google Scholar
• Kaplan I, Kapp DS, Bagshaw MA. Secondary external beam radiotherapy and hyperthermia for local recurrence after 125-Iodine implantation in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1991; 20: 554
   Web of Science ®Google Scholar
• Kalapurakal JA, Mittal BB, Sathiaseelan V. Reirradiation and external hyperthermia in locally advanced, radiation recurrent, hormone refractory prostate cancer: A preliminary report. Br J Radiology 2001; 74: 745–751
   PubMed Web of Science ®Google Scholar
• Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89(2)399–403
   PubMed Web of Science ®Google Scholar
• Ryu S, Brown SL, Kim SH, Khil MS, Kim JH. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996; 34(1)133–138
   PubMed Web of Science ®Google Scholar
• Pollack A, Zagars GK, Smith LG, Lee JJ, Eschenbach AC, Antolak JA, Starkschall G. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000; 18(23)3904–3911
   PubMed Web of Science ®Google Scholar
• van Vulpen M, De Leeuw AA, Van De Kamer JB, Kroeze H, Boon TA, Warlam-Rodenhuis CC, Lagendijk JJ, Battermann JJ. Comparison of intraluminal versus intra-tumoral temperature measurements in patients with locally advanced prostate cancer treated with coaxial TEM system: Report of a feasibily study. Int J Hyperthermia 2003; 19(5)481–497
   PubMed Web of Science ®Google Scholar
• Wust P, Gellerman J, Harder C, Tilly W, Rau B, Dinges S, Schlag P, Budach V, Felix R. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998; 41(5)1129–1137
   PubMed Web of Science ®Google Scholar
• van Vulpen M, De Leeuw JR, Van Gellekom MP, Van Der Hoeven J, De Graeff A, Van Moorselaar RJ, Van Der Tweel I, Hofman P, Lagendijk JJ, Battermann JJ. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia 2003; 19(4)402–413
   PubMed Web of Science ®Google Scholar
• Van Vulpen M, De Leeuw AA, Raaymakers BW, van Moorselaar RJ, Hofman P, Lagendijk JJ, Battermann JJ. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results. British J Urology 2004; 93(1)36–41
   Google Scholar
• Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005; 181(1)35–41
   PubMed Web of Science ®Google Scholar
• Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosh W, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005; 62(3)706–713
   PubMed Web of Science ®Google Scholar